David T Teachey
Overview
Explore the profile of David T Teachey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
11602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Newman H, Clark M, Wong D, Wu J, Brodeur G, Hunger S, et al.
Haematologica
. 2024 Feb;
109(9):3024-3030.
PMID: 38385299
No abstract available.
22.
Summers R, Teachey D, Hunger S
Blood
. 2024 Feb;
145(1):43-52.
PMID: 38364183
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a unique subtype of immature T-cell ALL that was initially associated with a dramatically inferior prognosis compared with non-ETP T-cell ALL (Not-ETP)...
23.
Kimura S, Polonen P, Montefiori L, Park C, Iacobucci I, Yeoh A, et al.
medRxiv
. 2023 Nov;
PMID: 37986997
Purpose: Gamma delta T-cell receptor-positive acute lymphoblastic leukemia (γδ T-ALL) is a high-risk but poorly characterized disease. Methods: We studied clinical features of 200 pediatric γδ T-ALL, and compared the...
24.
Magerus A, Rensing-Ehl A, Rao V, Teachey D, Rieux-Laucat F, Ehl S
J Allergy Clin Immunol
. 2023 Nov;
153(1):67-76.
PMID: 37977527
Chronic nonmalignant lymphoproliferation and autoimmune cytopenia are relevant manifestations of immunohematologic diseases of childhood. Their diagnostic classification is challenging but important for therapy. Autoimmune lymphoproliferative syndrome (ALPS) is a genetically...
25.
Schuelke M, Bassiri H, Behrens E, Canna S, Croy C, DiNofia A, et al.
Blood Adv
. 2023 Sep;
7(18):5603-5607.
PMID: 37721859
No abstract available.
26.
Wood B, Devidas M, Summers R, Chen Z, Asselin B, Rabin K, et al.
Blood
. 2023 Aug;
142(24):2069-2078.
PMID: 37556734
The early thymic precursor (ETP) immunophenotype was previously reported to confer poor outcome in T-cell acute lymphoblastic leukemia (T-ALL). Between 2009 and 2014, 1256 newly diagnosed children and young adults...
27.
Raetz E, Teachey D, Minard C, Liu X, Norris R, Denic K, et al.
Pediatr Blood Cancer
. 2023 Aug;
70(11):e30609.
PMID: 37553297
Background: Cyclin D has been shown to play an essential role in acute lymphoblastic leukemia (ALL) initiation and progression, providing rationale for targeting the CDK4/6-cyclin D complex that regulates cell...
28.
Raetz E, Bhojwani D, Devidas M, Gore L, Rabin K, Tasian S, et al.
Pediatr Blood Cancer
. 2023 Jul;
70 Suppl 6:e30585.
PMID: 37489549
Cure rates for acute lymphoblastic leukemia (ALL), the most common childhood cancer have steadily improved over the past five decades. This is due to intensifying systemic therapy, recognizing and treating...
29.
Saygin C, Giordano G, Shimamoto K, Eisfelder B, Thomas-Toth A, Venkataraman G, et al.
Clin Cancer Res
. 2023 Jun;
29(16):3151-3161.
PMID: 37363966
Purpose: Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options. We investigated mechanisms of resistance to BH3 mimetics in T-ALL to develop rational combination strategies. We also looked at the...
30.
Contreras Yametti G, Evensen N, Schloss J, Aldebert C, Duan E, Zhang Y, et al.
Blood Adv
. 2023 May;
7(15):3928-3931.
PMID: 37196626
No abstract available.